Li Y - Search Results

1

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA. Adelstein DJ, et al. Among authors: li y. J Clin Oncol. 2003 Jan 1;21(1):92-8. doi: 10.1200/JCO.2003.01.008. J Clin Oncol. 2003. PMID: 12506176 Clinical Trial.

2

Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.

Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA. Argiris A, et al. Among authors: li y. J Clin Oncol. 2004 Jan 15;22(2):262-8. doi: 10.1200/JCO.2004.08.039. J Clin Oncol. 2004. PMID: 14722034 Clinical Trial.

3

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.

Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, Forastiere AA; Eastern Cooperative Oncology Group. Gibson MK, et al. Among authors: li y. J Clin Oncol. 2005 May 20;23(15):3562-7. doi: 10.1200/JCO.2005.01.057. J Clin Oncol. 2005. PMID: 15908667 Clinical Trial.

4

Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.

Argiris A, Li Y, Forastiere A. Argiris A, et al. Among authors: li y. Cancer. 2004 Nov 15;101(10):2222-9. doi: 10.1002/cncr.20640. Cancer. 2004. PMID: 15452834 Free article.

5

Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology Group.

Langer CJ, Li Y, Jennings T, DeConti RC, Nair S, Cohen RB, Forastiere AA; Eastern Cooperative Oncology Group. Langer CJ, et al. Among authors: li y. Cancer Invest. 2004;22(6):823-31. doi: 10.1081/cnv-200039628. Cancer Invest. 2004. PMID: 15641479 Clinical Trial.

6

Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year follow-up.

Devlin PM, Kazakin J, Adak S, Li Y, Norris CM, Tishler RB, Clark JR, Busse PM, Posner MR. Devlin PM, et al. Among authors: li y. Am J Clin Oncol. 2004 Aug;27(4):369-75. doi: 10.1097/01.coc.0000071518.80534.ad. Am J Clin Oncol. 2004. PMID: 15289730 Clinical Trial.

7

Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).

Bhatia AK, Lee JW, Pinto HA, Jacobs CD, Limburg PJ, Rubin P, Arusell RM, Dunphy EP, Khandekar JD, Reiner SA, Baez-Diaz L, Celano P, Li S, Li Y, Burtness BA, Adams GL, Pandya KJ. Bhatia AK, et al. Among authors: li s, li y. Cancer. 2017 Dec 1;123(23):4653-4662. doi: 10.1002/cncr.30920. Epub 2017 Aug 7. Cancer. 2017. PMID: 28786105 Free PMC article. Clinical Trial.

8

Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?

Wong SJ, Machtay M, Li Y. Wong SJ, et al. Among authors: li y. J Clin Oncol. 2006 Jun 10;24(17):2653-8. doi: 10.1200/JCO.2005.05.3850. J Clin Oncol. 2006. PMID: 16763279 Review.

9

Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group.

Gilbert J, Li Y, Pinto HA, Jennings T, Kies MS, Silverman P, Forastiere AA. Gilbert J, et al. Among authors: li y. Head Neck. 2006 Mar;28(3):197-204. doi: 10.1002/hed.20327. Head Neck. 2006. PMID: 16470745 Clinical Trial.

10

Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.

Haddad R, Tishler R, Wirth L, Norris CM, Goguen L, Sullivan C, O'Donnell L, Li Y, Posner M. Haddad R, et al. Among authors: li y. Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):678-81. doi: 10.1001/archotol.132.6.678. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16785415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239,821 results

Search Page

Filters